1.41
Finanzdaten der Cabaletta Bio Inc-Aktie (CABA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
17.44%
52.02
|
44.30 | 42.61 | 46.59 | 45.91 |
| Interest Income/Expense |
18.71%
0.517
|
0.636 | 0.555 | 0.584 | 0.571 |
| Operating Income/Loss |
17.44%
-52.02
|
-44.30 | -42.61 | -46.59 | -45.91 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
17.24%
-51.02
|
-43.52 | -41.92 | -44.87 | -45.13 |
| Basic Average Shares |
34.93%
151.16
|
112.03 | - | - | - |
| Diluted Average Shares |
34.93%
151.16
|
112.03 | - | - | - |
| Basic Earnings Per Share |
12.82%
-0.34
|
-0.39 | - | -0.44 | -0.73 |
| Diluted Earnings Per Share |
12.82%
-0.34
|
-0.39 | - | -0.44 | -0.73 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):